FI880282L - Menetelmä uusien terapeuttisesti käyttökelpoisten 3-aryyli-5-alkyylisulfinyyli- ja sulfonyyli-4H-1,2,4-triatsolien valmistamiseksi - Google Patents
Menetelmä uusien terapeuttisesti käyttökelpoisten 3-aryyli-5-alkyylisulfinyyli- ja sulfonyyli-4H-1,2,4-triatsolien valmistamiseksi Download PDFInfo
- Publication number
- FI880282L FI880282L FI880282A FI880282A FI880282L FI 880282 L FI880282 L FI 880282L FI 880282 A FI880282 A FI 880282A FI 880282 A FI880282 A FI 880282A FI 880282 L FI880282 L FI 880282L
- Authority
- FI
- Finland
- Prior art keywords
- triazoles
- alkylsulfinyl
- sulfonyl
- aryl
- preparation
- Prior art date
Links
- WOKITPBOBBLYAI-UHFFFAOYSA-N 3-sulfonyl-1,2-dihydro-1,2,4-triazole Chemical class O=S(=O)=C1N=CNN1 WOKITPBOBBLYAI-UHFFFAOYSA-N 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
- C07D249/10—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D249/12—Oxygen or sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Neurology (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Pain & Pain Management (AREA)
- Anesthesiology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US706387A | 1987-01-27 | 1987-01-27 | |
| US706387 | 1987-01-27 | ||
| US07/126,191 US4900743A (en) | 1987-01-27 | 1987-12-04 | 3-aryl-5-alkylthio-4H-1,2,4-triazoles |
| US12619187 | 1987-12-04 |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| FI880282A0 FI880282A0 (fi) | 1988-01-22 |
| FI880282L true FI880282L (fi) | 1988-07-28 |
| FI91526B FI91526B (fi) | 1994-03-31 |
| FI91526C FI91526C (fi) | 1994-07-11 |
Family
ID=26676435
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FI880282A FI91526C (fi) | 1987-01-27 | 1988-01-22 | Menetelmä uusien terapeuttisesti käyttökelpoisten 3-aryyli-5-alkyylisulfinyyli- ja sulfonyyli-4H-1,2,4-triatsolien valmistamiseksi |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US4900743A (fi) |
| EP (1) | EP0276793B1 (fi) |
| JP (1) | JP2537651B2 (fi) |
| KR (1) | KR960007166B1 (fi) |
| CN (1) | CN1023480C (fi) |
| AR (1) | AR244682A1 (fi) |
| AU (1) | AU601013B2 (fi) |
| CA (1) | CA1312605C (fi) |
| DE (1) | DE3881712T2 (fi) |
| DK (1) | DK171599B1 (fi) |
| ES (1) | ES2058144T3 (fi) |
| FI (1) | FI91526C (fi) |
| HU (1) | HU205747B (fi) |
| IE (1) | IE61188B1 (fi) |
| IL (1) | IL85185A (fi) |
| NO (1) | NO166642C (fi) |
| NZ (1) | NZ223260A (fi) |
| PH (1) | PH24513A (fi) |
| PT (1) | PT86623B (fi) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH03501731A (ja) * | 1987-12-31 | 1991-04-18 | スミスクライン・ベックマン・コーポレイション | ４‐アラルキル‐５‐置換‐１，２，４‐トリアゾール‐５‐チオール類 |
| AU644500B2 (en) * | 1990-12-20 | 1993-12-09 | Merrell Dow Pharmaceuticals Inc. | 3-aryl-5-alkylthio-4h-1,2,4-triazoles for treatment of hyperreflexia due to spinal trauma |
| DE4339412A1 (de) * | 1993-11-18 | 1995-05-24 | Bayer Ag | Verfahren und neue Zwischenprodukte zur Herstellung von Triazolinonen |
| AR032653A1 (es) * | 2001-02-09 | 2003-11-19 | Telik Inc | Inhibidores heterociclicos del trasportador de glicina 2 composiciones farmaceuticas, uso y metodos. |
| CN1736381B (zh) * | 2005-08-11 | 2010-09-08 | 沈阳药科大学 | 吗啉甲基萘满酮用于制备平滑肌解痉剂的用途 |
| MX2011005981A (es) * | 2008-12-12 | 2011-06-27 | Astrazeneca Ab | Nuevo proceso para preparar 4-[4-metil-5-(alquiltio c1-10/aril c5-10-alquilto c1-6)-4h-1,2,4-triazol-3-il]piridinas. |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HU193891B (en) * | 1984-02-07 | 1987-12-28 | Gyogyszerkutato Intezet | Process for production of new derivatives of 1,2,4-triasole |
-
1987
- 1987-12-04 US US07/126,191 patent/US4900743A/en not_active Expired - Lifetime
-
1988
- 1988-01-21 NZ NZ223260A patent/NZ223260A/en unknown
- 1988-01-21 CA CA000557078A patent/CA1312605C/en not_active Expired - Fee Related
- 1988-01-22 FI FI880282A patent/FI91526C/fi not_active IP Right Cessation
- 1988-01-22 AU AU10728/88A patent/AU601013B2/en not_active Ceased
- 1988-01-25 AR AR88309910A patent/AR244682A1/es active
- 1988-01-25 HU HU88280D patent/HU205747B/hu not_active IP Right Cessation
- 1988-01-25 EP EP88101023A patent/EP0276793B1/en not_active Expired - Lifetime
- 1988-01-25 ES ES88101023T patent/ES2058144T3/es not_active Expired - Lifetime
- 1988-01-25 DE DE88101023T patent/DE3881712T2/de not_active Expired - Fee Related
- 1988-01-25 IL IL8518588A patent/IL85185A/en not_active IP Right Cessation
- 1988-01-26 DK DK035488A patent/DK171599B1/da not_active IP Right Cessation
- 1988-01-26 CN CN88100346A patent/CN1023480C/zh not_active Expired - Fee Related
- 1988-01-26 NO NO880337A patent/NO166642C/no unknown
- 1988-01-26 KR KR1019880000562A patent/KR960007166B1/ko not_active Expired - Fee Related
- 1988-01-26 PT PT86623A patent/PT86623B/pt not_active IP Right Cessation
- 1988-01-26 IE IE19188A patent/IE61188B1/en not_active IP Right Cessation
- 1988-01-27 JP JP63014787A patent/JP2537651B2/ja not_active Expired - Fee Related
- 1988-01-27 PH PH36413A patent/PH24513A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| FI91526C (fi) | 1994-07-11 |
| KR880008999A (ko) | 1988-09-13 |
| NO166642B (no) | 1991-05-13 |
| CN88100346A (zh) | 1988-11-02 |
| AR244682A1 (es) | 1993-11-30 |
| IL85185A (en) | 1996-03-31 |
| KR960007166B1 (ko) | 1996-05-29 |
| HU205747B (en) | 1992-06-29 |
| DE3881712D1 (de) | 1993-07-22 |
| CA1312605C (en) | 1993-01-12 |
| AU601013B2 (en) | 1990-08-30 |
| EP0276793B1 (en) | 1993-06-16 |
| JP2537651B2 (ja) | 1996-09-25 |
| NZ223260A (en) | 1991-07-26 |
| FI91526B (fi) | 1994-03-31 |
| DE3881712T2 (de) | 1993-12-23 |
| AU1072888A (en) | 1988-07-28 |
| DK35488A (da) | 1988-07-28 |
| DK35488D0 (da) | 1988-01-26 |
| NO880337D0 (no) | 1988-01-26 |
| HUT47257A (en) | 1989-02-28 |
| NO880337L (no) | 1988-07-28 |
| PT86623A (pt) | 1988-02-01 |
| CN1023480C (zh) | 1994-01-12 |
| IE61188B1 (en) | 1994-10-19 |
| EP0276793A2 (en) | 1988-08-03 |
| DK171599B1 (da) | 1997-02-17 |
| ES2058144T3 (es) | 1994-11-01 |
| PT86623B (pt) | 1993-01-29 |
| EP0276793A3 (en) | 1988-09-21 |
| IL85185A0 (en) | 1988-07-31 |
| NO166642C (no) | 1991-08-21 |
| PH24513A (en) | 1990-07-18 |
| FI880282A0 (fi) | 1988-01-22 |
| JPS63201176A (ja) | 1988-08-19 |
| US4900743A (en) | 1990-02-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO179584C (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive 2-acylaminotiazoler | |
| ZA887889B (en) | Process for the manufacture of 1,1,1-trifluorodichloroethylene and 1,1,1,2-tetrafluorochloroethylene | |
| FI875660L (fi) | Menetelmä terapeuttisesti käyttökelpoisten 5-fenyyli-2-pyrimidinonijohdannaisten valmistamiseksi | |
| FI875024A7 (fi) | Menetelmä terapeuttisesti käyttökelpoisten 1-alkyyli-6-halogeenitetrahydronaftaleenijohdannaisten valmistamiseksi | |
| PT86875A (pt) | Process for the preparation of phenylcarbamate | |
| NO178619C (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive di-t-butylfenoler | |
| FI872379A7 (fi) | Menetelmä farmakologisesti vaikuttavien 1,5-diaryyli-3-(w-substituoitu-alempi-alkyyli)-pyratsolien valmistamiseksi | |
| EP0302020A3 (en) | Process for the preparation of 2,2,6,6-tetramethyl-4-piperidyl-amines | |
| FI881900A7 (fi) | Analogiamenetelmä terapeuttisesti käyttökelpoisten substituoitujen imidatsolyylialkyylipiperatsiini- ja -diatsepiinijohdannaisten valmistamiseksi | |
| FI891338A0 (fi) | Parannus menetelmään 2',3'-dideoksi-2',3'-didehydronukleosidien valmistamiseksi | |
| FI895417A0 (fi) | Menetelmä uusien terapeuttisesti käyttökelpoisten 2'-halometylideeninukleosidien valmistamiseksi | |
| FI895393A0 (fi) | Menetelmä terapeuttisesti käyttökelpoisten alkyylisubstituoitujen 2-alkyyliamiinibentsopyran-6-olien valmistamiseksi | |
| FI906408L (fi) | Menetelmä terapeuttisesti käyttökelpoisten 2-aminopyrimidiini-4-karboksamidijohdannaisten valmistamiseksi | |
| FI880467A0 (fi) | Menetelmä terapeuttisesti käyttökelpoisten substituoitujen 3,4-dihydro-2H-bentsopyraanien valmistamiseksi | |
| FI884553A7 (fi) | Analogiamenetelmä terapeuttisesti käyttökelpoisten 9-aminotetrahydroakridiinijohdannaisten valmistamiseksi | |
| FI881892A7 (fi) | Menetelmä uusien, terapeuttisesti käyttökelpoisten 1,2,5,6-tetrahydropyridiinijohdannaisten valmistamiseksi | |
| FI885518A7 (fi) | Menetelmä uusien terapeuttisesti käyttökelpoisten 4,5-dihydro-4-okso-5-isopropyyli-imidatso/1,5-a/kinoksaliinijohdannaisten valmistamiseksi | |
| FI91961C (fi) | Menetelmä (S)- -etyyli-2-okso-1-pyrrolidiiniasetamidin valmistamiseksi | |
| FI894546A7 (fi) | Menetelmä uusien 2'-halogeenimetylideeni-, 2'-etenylideeni- ja 2'-etynyyliadenosiinijohdannaisten valmistamiseksi | |
| IL82858A0 (en) | Process for the preparation of 1,2,5,6,9,10-hexabromo-cyclododecane | |
| NO174203C (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive | |
| NO174774C (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive benzodiazepiner | |
| FI892946A7 (fi) | Menetelmä uusien terapeuttisesti käyttökelpoisten 2,3,4,5-tetrahydro-1H-3-bentsoatsepiinijohdannaisten valmistamiseksi | |
| FI893682L (fi) | Menetelmä terapeuttisesti käyttökelpoisten 1,2,5-ditiatsosiinijohdannaisten valmistamiseksi | |
| FI880282L (fi) | Menetelmä uusien terapeuttisesti käyttökelpoisten 3-aryyli-5-alkyylisulfinyyli- ja sulfonyyli-4H-1,2,4-triatsolien valmistamiseksi |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| BB | Publication of examined application | ||
| MM | Patent lapsed |
Owner name: MERRELL DOW PHARMACEUTICALS INC. |